Re: Lipitor in emerging markets From today's WSJ article in #msg-75408172: The company will continue to push the drug in emerging markets like China, where the company sees opportunities for multibillion dollar sales. Indeed. Lipitor will continue to be a big-selling drug for PFE even when it is off-patent everywhere. p.s. #msg-62904460, posted exactly one year ago today, is on-topic.